Browse > Article

Macrophage Migration Inhibitory Factor (MIF) Induced Stromal Cell-derived Factor 1 (SDF-l) Production Via Nuclear Factor KappaB (NF-${\kappa}B$) Signaling in Rheumatoid Arthritis Fibroblast Like Synoviocytes (RA-FLS)  

Cho, Mi-La (Rheumatism Research Center (RhRC), The Catholic University of Korea)
Park, Mi-Kyung (Rheumatism Research Center (RhRC), The Catholic University of Korea)
Kim, Kyoung-Woon (Rheumatism Research Center (RhRC), The Catholic University of Korea)
Oh, Hye-Jwa (Rheumatism Research Center (RhRC), The Catholic University of Korea)
Lee, Seon-Yeong (Rheumatism Research Center (RhRC), The Catholic University of Korea)
Park, Jin-Sil (Rheumatism Research Center (RhRC), The Catholic University of Korea)
Heo, Yu-Jung (Rheumatism Research Center (RhRC), The Catholic University of Korea)
Ju, Ji-Hyeon (Rheumatism Research Center (RhRC), The Catholic University of Korea)
Min, Jun-Ki (Rheumatism Research Center (RhRC), The Catholic University of Korea)
Lee, Sang-Heon (Division of Rheumatology, Department of Medicine, School of Medicine, Konkuk University)
Park, Sung-Hwan (Rheumatism Research Center (RhRC), The Catholic University of Korea)
Kim, Ho-Youn (Rheumatism Research Center (RhRC), The Catholic University of Korea)
Publication Information
IMMUNE NETWORK / v.7, no.1, 2007 , pp. 39-47 More about this Journal
Abstract
Background: Stromal cell-derived factor (SDF)-1 is a potent chemoattractant for activated T cells into the inflamed Rheumatoid arthritis (RA) synovium. To determine the effect of macrophage migration inhibitory factor (MIF) on the production of SDF-1 in the inflamed RA synovium. Methods: The expression of SDF-1 and MIF in RA and Osteoarthritis (OA) synovium was examined by immunohistochemical staining. The SDF-1 was quantified by RT-PCR and ELISA after RA fibroblast like synoviocyte (FLS) were treated with MIF in the presence and absence of inhibitors of intracellular signal molecules. The synovial fluid (SF) and serum levels of MIF and SDF-1 in RA, OA and healthy control were measured by ELISA. Results: Expression of SDF-1 and MIF in synovium was higher in RA patients than in OA patients. The production of SDF-1 was enhanced in RA FLS by MIF stimulation. Such effect of MIF was blocked by the inhibitors of NF-${\kappa}B$. Concentrations of SDF-1 in the serum and SF were higher in RA patients than in OA patients and healthy control. SDF-1 and MIF was overexpressed in RA FLS, and MIF could up-regulate the production of SDF-1 in RA FLS via NF-${\kappa}B$-mediated pathways. Conclusion: These results suggest that an inhibition of interaction between MIF from T cells and SDF-1 of FLS may provide a new therapeutic approach in the treatment of RA.
Keywords
SDF-1; MIF; rheumatoid arthritis; FLS; NF-${\kappa}B$;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Kanbe K, Takagishi K, Chen Q: Stimulation of matrix metalloprotease 3 release from human chondrocytes by the interaction of stromal cell-derived factor 1 and CXC chemokine receptor 4. Arthritis Rheum 46;130-137, 2002   DOI   ScienceOn
2 Grassi F, Cristino S, Toneguzzi S, Piacentini A, Facchini A, Lisignoli G: CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients. J Cell Physiol 199;244-251, 2004   DOI   ScienceOn
3 Tamamura H, Fujisawa M, Hiramatsu K, Mizumoto M, Nakashima H, Yamamoto N, Otaka A, Fujii N: Identification of a CXCR4 antagonist, a T140 analog, as an anti-rheumatoid arthritis agent. FEBS Lett 569;99-104, 2004   DOI   ScienceOn
4 David JR: Delayed hypersensitivity in vitro: its mediation by cell free substances formed by lymphoid cell-antigen interaction. Pathology 56;72-77, 1966
5 Nathan CF, Karnovsky ML, David JR: Alterations of macrophage functions by mediator from lymphocytes. J Exp Med 133;1356-1376, 1971   DOI   ScienceOn
6 Morand EF, Bucala R, Leech M: Macrophage migration inhibitory factor: an emerging therapeutic target in rheumatoid arthritis. Arthritis Rheum 48;291-299, 2003   DOI   ScienceOn
7 Leech M, Metz C, Hall P, Hutchinson P, Gianis K, Smith M, Weedon H, Holdsworth SR, Bucala R, Morand EF: Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum 42;1601-1608, 1999   DOI   ScienceOn
8 Morand EF, Leech M, Weedon H, Metz C, Bucala R, Smith MD: Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlations. Rheumatology 41;558-562, 2002   DOI   ScienceOn
9 Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Linanq MH, Luthra HS: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31;315-324, 1988   DOI   ScienceOn
10 Kim KW, Cho ML, Kim HR, Ju JH, Park MK, Oh HJ, Kim JS, Park SH, Lee SH, Kim HY: Up-regulation of stromal cell-derived factor 1 (CXCL12) production in rheumatoid synovial fibroblasts through interactions with T lymphocytes: Role of interleukin-17 and CD40L-CD40 interaction. Arthritis Rheum 56;1076-1086 2007   DOI   ScienceOn
11 Weyand CM, Goronzy JJ: T-cell responses in rheumatoid arthritis: systemic abnormalities-local disease. Curr Opin Rheumatol 11;210-217, 1999   DOI
12 Mbemba E, Benjouad A, Saffar L, Gattegno L: Glycans and proteoglycans are involved in the interactions of human immunodeficiency virus type 1 envelope glycoprotein and of SDF-1alpha with membrane ligands of CD4(+) CXCR4(+) cells. Virology 265;354-364, 1999   DOI   ScienceOn
13 Hitchon C, Wong K, Ma G, Reed J, Lyttle D, El-Gabalawy H: Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts. Arthritis Rheum 46;2587-2597, 2002   DOI   ScienceOn
14 Radstake TR, Sweep FC, Welsing P Franke B, Vermeulen SH, Geurts-Moespot A, Calandra T, Donn R, van Riel PL: Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. Arthritis Rheum 52;3020-3029, 2005   DOI   ScienceOn
15 Ren Y, Tsui HT, Poon RT, Nq IO, Li Z, Chen Y, Jianq G, Lau C, Yu WC, Bacher M, Fan ST: Macrophage migration inhibitory factor: roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma. Int J Cancer 107;22-29, 2003   DOI   ScienceOn
16 Goronzy JJ, Weyand CM: Thymic function and peripheral T-cell homeostasis in rheumatoid arthritis. Trends Immunol 22;251-255, 2001   DOI   ScienceOn
17 Mittal GA, Joshi VR, Deshpande A: Stromal cell-derived factor-1 alpha in rheumatoid arthritis. Rheumatology (Oxford) 42;915-916, 2003   DOI   ScienceOn
18 Lacey D, Sampey A, Mitchell R, Bucala R, Santos L, Leech M, Morand E: Control of fibroblast-like synoviocyte proliferation by macrophage migration inhibitory factor. Arthritis Rheum 48;103-109, 2003   DOI   ScienceOn
19 Aarvak T, Narvig JB: Cell-cell interactions in synovitis: antigen presenting cells and T cell interaction in rheumatoid arthritis. Arthritis Res 3;13-317, 2001   DOI   ScienceOn
20 Cho ML, Cho CS, Min SY, Kim SH, Lee SS, Kim WU, Min DJ, Min JK, Youn J, Hwang SY, Park SH, Kim HY: Cyclosporine inhibition of vascular endothelial growth factor production in rheumatoid synovial fibroblasts. Arthritis Rheum 46;1202-1209, 2002   DOI   ScienceOn
21 Matsuda A, Tagawa Y, Matsuda H, Nishihira J: Identification and immunohistochemical localization of macrophage migration inhibitory factor in human cornea. FEBS Lett 385;225-228, 1996   DOI
22 Chen X, Beutler JA, McCloud TG, Loehfelm A, Yang L, Dong HF, Chertov OY, Salcedo R, Oppenheim JJ, Howard OM: Tannic Acid Is an Inhibitor of CXCL12 (SDF-$\alpha$)/CXCR4 with Antiangiogenic Activity. Clin Cancer Res 9;3115-3123, 2003   PUBMED
23 Selvi E, Tripodi SA, Catenaccio M, Lorenzini S, Chindamo D, Manganelli S, Romaqnoli R, Letta F, Paulesu L, Miracco C, Cintorino M, Marcolonqo R: Expression of macrophage migration inhibitory factor in diffuse systemic sclerosis. Ann Rheum Dis 62;460-464, 2003   DOI
24 Fedyk ER, Jones D, Critchley HO, Phipps RP, Blieden TM, Springer TA: Expression of stromal-derived factor-1 is decreased by IL-1 and TNF and in dermal wound healing. J Immunol 166;5749-5754, 2001   DOI   PUBMED
25 Dubois-Laforgue D, Hendel H, Caillat-Zucman S, Zagury JF, Winkler C, Boitard C, Timsit J: A common stromal cellderived factor-1 chemokine gene variant is associated with the early onset of type 1 diabetes. Diabetes 50;1211-1213, 2001   DOI   ScienceOn
26 Blades MC, Ingegnoli F, Wheller SK, Manzo A, Wahid S, Panayi GS, Perretti M, Pitzalis C: Stromal cell-derived factor 1 (CXCL12) induces monocyte migration into human synovium transplanted onto SCID Mice. Arthritis Rheum 46;824-836, 2002   DOI   ScienceOn
27 Lee SS, Joo YS, Kim WU, Min DJ, Min JK, Park SH, Cho CS, Kim HY: Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis. Clin Exp Rheumatol 19;321-324, 2001   PUBMED
28 Ren Y, Law S, Huang X, Lee PY, Bacher M, Srivastava G, Wonq J: Macrophage migration inhibitory factor stimulates angiogenic factor expression and correlates with differentiation and lymph node status in patients with esophageal squamous cell carcinoma. Ann Surg 242;55-63, 2005   DOI   ScienceOn
29 Bacher M, Metz CN, Calandra T, Mayer K, Chesney J, Lohoff M, Gemsa D, Donnelly T, Bucala R: An essential regulatory role for macrophage migration inhibitor factor in T-cell activation. Proc Natl Acad Sci USA 93;7849-7854, 1996
30 Onodera S, Suzuki K, Matsuno T, Kaneda K, Kuriyama T, Nishihira J: Identification of macrophage migration inhibitory factor in murine neonatal calvariae and osteoblasts. Immunology 89;430-435, 1996   DOI
31 Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donelly T, Cerami A, Cucala R: MIF as a glucocorticoidinduced modulator of cytokine production. Nature 377;68-71, 1995   DOI   ScienceOn
32 Pablos JL, Santiago B, Galindo M, Torres C, Brehmer MT, Blanco FJ, Garcia-Lazaro FJ: Synoviocyte-derived CXCL12 is displayed on endothelium and induces angiogenesis in rheumatoid arthritis. J Immunol 170;2147-2152, 2003   DOI   PUBMED
33 De Klerck B, Geboes L, Hatse S, Kelchtermans H, Meyvis Y, Vermeire K, Bridger G, Billiau A, Schols D, Matthys P: Pro-inflammatory properties of stromal cell-derived factor-1 (CXCL12) in collagen-induced arthritis. Arthritis Res Ther 7;R1208-R1220, 2005   DOI   PUBMED   ScienceOn
34 Lolis E: Glucocorticoid counter regulation: macrophage migration inhibitory factor as a target for drug discovery. Curr Opin Pharmacol 1;662-668, 2001   DOI   ScienceOn
35 Meazza C, Travaglino P, Pignatti P, Magni-Manzoni S, Ravelli A, Martini A, De Benedetti F: Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis. Arthritis Rheum 46;232-237, 2002   DOI   ScienceOn
36 Munaut C, Boniver J, Foidart JM Deprez M: Macrophage migration inhibitory factor (MIF) expression in human glioblastomas correlates with vascular endothelial growth factor (VEGF) expression. Neuropathol Appl Neurobiol 28;452-460, 2002   DOI
37 Shirozu M, Nakano T, Inazawa J, Tashiro K, Tada H, Shinohara T, Honjo T: Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. Genomics 28;495-500, 1995   DOI   ScienceOn
38 Hoy MD, O'Donnell JL, Hart DN: Dual CD45RA, CD45RO positive T-lymphocytes within rheumatoid arthritic joints. Pathology 25;167-173, 1993   DOI
39 Kucia M, Jankowski K, Reca R, Wysoczynski M, Bandura L, Allendorf DJ, Zhang J, Ratajczak J, Ratajczak MZ: CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol 35;233-245, 2004   DOI
40 Bloom BR, Bennet B: Mechanism of a reaction in vitro associated with delayed hypersensitivity. Science 153;80-82, 1966   DOI   ScienceOn
41 Nanki T, Hayashida K, El-Gabalawy HS, Suson S, Shi K, Girschick HJ, Yavuz S, Lipsky PE: Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in $CD4^{+}$ T cell accumulation in rheumatoid arthritis synovium. J Immunol 165;6590-6598, 2000   DOI   PUBMED
42 Shimizu T, Ohkawara A, Nishihira J, Sakamoto W: Identification of macrophage migration inhibitory factor (MIF) in human skin and its immunohistochemical localization. FEBS Lett 381;199-202, 1996   DOI   ScienceOn
43 Burger JA, Kipps TJ: CXCR4: A key receptor in the cross talk between tumor cells and their microenvironment. Blood 107;1761-1767, 2006   DOI   ScienceOn
44 Hitchon C, Wong K, Ma G, Reed J, Lyttle D, El-Gabalawy H: Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts. Arthritis Rheum 46;2587-2597, 2002   DOI   ScienceOn